Literature DB >> 2684084

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.

W K Goodman1, L H Price, S A Rasmussen, C Mazure, R L Fleischmann, C L Hill, G R Heninger, D S Charney.   

Abstract

The Yale-Brown Obsessive Compulsive Scale was designed to remedy the problems of existing rating scales by providing a specific measure of the severity of symptoms of obsessive-compulsive disorder that is not influenced by the type of obsessions or compulsions present. The scale is a clinician-rated, 10-item scale, each item rated from 0 (no symptoms) to 4 (extreme symptoms) (total range, 0 to 40), with separate subtotals for severity of obsessions and compulsions. In a study involving four raters and 40 patients with obsessive-compulsive disorder at various stages of treatment, interrater reliability for the total Yale-Brown Scale score and each of the 10 individual items was excellent, with a high degree of internal consistency among all item scores demonstrated with Cronbach's alpha coefficient. Based on pretreatment assessment of 42 patients with obsessive-compulsive disorder, each item was frequently endorsed and measured across a range of severity. These findings suggest that the Yale-Brown Scale is a reliable instrument for measuring the severity of illness in patients with obsessive-compulsive disorder with a range of severity and types of obsessive-compulsive symptoms.

Entities:  

Mesh:

Year:  1989        PMID: 2684084     DOI: 10.1001/archpsyc.1989.01810110048007

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  1238 in total

1.  Brief report: a pilot open clinical trial of intravenous immunoglobulin in childhood autism.

Authors:  G DelGiudice-Asch; L Simon; J Schmeidler; C Cunningham-Rundles; E Hollander
Journal:  J Autism Dev Disord       Date:  1999-04

Review 2.  The pathophysiology and treatment of autism.

Authors:  D J Posey; C J McDougle
Journal:  Curr Psychiatry Rep       Date:  2001-04       Impact factor: 5.285

3.  A brief interview for assessing compulsive hoarding: the Hoarding Rating Scale-Interview.

Authors:  David F Tolin; Randy O Frost; Gail Steketee
Journal:  Psychiatry Res       Date:  2010-05-10       Impact factor: 3.222

4.  Minocycline augmentation of pharmacotherapy in obsessive-compulsive disorder: an open-label trial.

Authors:  Carolyn I Rodriguez; James Bender; Sue M Marcus; Michael Snape; Moira Rynn; Helen Blair Simpson
Journal:  J Clin Psychiatry       Date:  2010-09       Impact factor: 4.384

5.  Evidence for cortical inhibitory and excitatory dysfunction in obsessive compulsive disorder.

Authors:  Margaret A Richter; Danilo R de Jesus; Sylco Hoppenbrouwers; Melissa Daigle; Jasna Deluce; Lakshmi N Ravindran; Paul B Fitzgerald; Zafiris J Daskalakis
Journal:  Neuropsychopharmacology       Date:  2011-12-14       Impact factor: 7.853

6.  Positron emission tomography experience with 2-[¹⁸F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[¹⁸F]FA) in the living human brain of smokers with paranoid schizophrenia.

Authors:  James Robert Brašić; Nicola Cascella; Anil Kumar; Yun Zhou; John Hilton; Vanessa Raymont; Andrew Crabb; Maria Rita Guevara; Andrew G Horti; Dean Foster Wong
Journal:  Synapse       Date:  2011-12-29       Impact factor: 2.562

7.  EEG-vigilance differences between patients with borderline personality disorder, patients with obsessive-compulsive disorder and healthy controls.

Authors:  Ulrich Hegerl; Michael Stein; Christoph Mulert; Roland Mergl; Sebastian Olbrich; Eva Dichgans; Dan Rujescu; Oliver Pogarell
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04       Impact factor: 5.270

Review 8.  Role of antiepileptic drugs in the management of eating disorders.

Authors:  Susan L McElroy; Anna I Guerdjikova; Brian Martens; Paul E Keck; Harrison G Pope; James I Hudson
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

9.  Anatomic alterations across amygdala subnuclei in medication-free patients with obsessive-compulsive disorder.

Authors:  Lianqing Zhang; Xinyu Hu; Lu Lu; Bin Li; Xiaoxiao Hu; Xuan Bu; Hailong Li; Shi Tang; Yingxue Gao; Yanchun Yang; John A Sweeney; Qiyong Gong; Xiaoqi Huang
Journal:  J Psychiatry Neurosci       Date:  2020-09-01       Impact factor: 6.186

10.  Value-based decision making under uncertainty in hoarding and obsessive- compulsive disorders.

Authors:  Helen Pushkarskaya; David Tolin; Lital Ruderman; Daniel Henick; J MacLaren Kelly; Christopher Pittenger; Ifat Levy
Journal:  Psychiatry Res       Date:  2017-08-24       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.